Pin-ing down PMN priming ----------------------------------------------------------------------------------------------------------------William M. Nauseef UNIVERSITY OF IOWA/VA MEDICAL CENTER
In this issue of Blood, Boussetta et al provide novel insights into how TNF␣ primes human neutrophils and report that a specific conformational change switches the phagocyte NADPH oxidase into a more productive state. 1 T he phagocyte NADPH oxidase generates an array of reactive oxidants that synergize with granule contents and circulating host proteins to mediate efficient antimicrobial activity in the neutrophil phagosome. In resting neutrophils, the phagocyte oxidase is unassembled and inactive, as the individual components are spatially segregated in naive phagocytes. Upon exposure to suitable stimuli, agonist-dependent changes in the cytoplasmic oxidase components p47 phox and Rac2 result in their translocation to the phagosomal membrane and culminate in the assembly of an active oxidase complex. 2 However, activation of the phagocyte NADPH oxidase has nuances beyond simply toggling from resting to activated status; neutrophils can adopt a "primed" phenotype, whereby suboptimal concentrations of typical agonists or exposure to agents that do not directly stimulate resting neutrophils can elicit robust oxidase activity. For example, pretreatment of neutrophils with tumor necrosis factor ␣ (TNF␣), an agent that does not directly trigger NADPH oxidase activity, renders neutrophils responsive to suboptimal concentrations of formylated peptides, such as the formylated tripeptide, formyl-methionylleucylphenylalanine (fMLF). Agents that have the capacity to prime neutrophils include cytokines, such as TNF␣, microbial components, ␤ 2 integrin agonists, extracellular matrix proteins, and several pharmacologic agents (reviewed in El-Benna et al 3 ). Not only have a variety of agents that prime neutrophils been identified, but several phenotypic changes in primed neutrophils have also been described, including transcriptional changes, increases in membrane flavocytochrome b 558 expression, augmented G-protein activity, reorganization of plasma membranes, and partial phosphorylation of p47 phox .
The El-Benna laboratory previously demonstrated that phosphorylation of 345 Ser in p47 phox is required for TNF␣-dependent priming of the phagocyte NADPH oxidase. 4 In this issue, the same laboratory now reports that Pin1, a peptidyl prolyl cis-trans isomerase (PPI), catalyzes a conformational change in p47 phox that is required for oxidase priming by TNF␣. Appreciation of the beauty of this novel insight requires some background information.
Because of its ringed structure, proline can profoundly alter protein conformation, depending on whether it is in the cis or trans configuration with respect to the peptide bond. Cis-trans isomerization of proline occurs at a very slow rate, on the order of minutes, unless catalyzed by a PPI. The conformational switch provided by prolyl cis-trans isomerization participates in modulation of a wide range of cellular processes. 5, 6 The subfamily of PPI represented by Pin1 is unique in its ability to promote efficient isomerization of prolines adjacent to phosphorylated Ser or Thr residues, 7 thereby coupling Pin1 binding and activity to regulation of signal transduction systems that rely on proline-directed phosphorylation.
Boussetta et al demonstrate for the first time that Pin1 is present in the cytoplasm of human neutrophils and is required for TNF␣ priming of the NADPH oxidase. Furthermore, 345 Ser, phosphorylated in response to TNF␣, binds Pin1, which in turn triggers conformational changes in p47 phox , rendering neighboring serine residues susceptible to phosphorylation by protein kinases (see figure ). The subsequent serine phosphorylations elicit another conformational change, which exposes otherwise cryptic SH3 motifs that then dock at the membrane with proline-rich regions of p22 phox , the light subunit of flavocytochrome b 558 , resulting in stable assembly of the oxidase. Overall, the enlistment of Pin1 by TNF␣ treatment changes the configuration of p47 phox and the phenotype of the NADPH oxidase, thereby amplifying its responsiveness to subsequent agonist challenge.
The most obvious consequence of Pin1-dependent cis-trans prolyl isomerization is increased oxidase activity. Whether the augmented output reflects more efficient oxidase assembly, increased specific activity of the assembled oxidase, or both is not yet known. Application of the broken cell superoxidegenerating system to this question may provide insights into the underlying mechanism. In addition, it is worth considering that increased oxidase activity is not the only means by which more oxidants could be produced. Termination of oxidase activity, an event both incompletely understood and characterized, may be delayed or inhibited by TNF␣ treatment. If dephosphorylation of one or more serines in p47 phox normally contributes to termination of oxidase activity, a conformational shift from trans to cis might render the site(s) resistant to phosphatase action, as some phosphatases dephosphorylate exclusively trans configuration of phosphorylated Ser/Thr, 8 and thereby stabilize the oxidase complex assembled and active at the membrane. Like increased activation, delayed termination of the NADPH oxidase would result in greater oxidant production.
The report by Boussetta et al adds to our understanding another critical step in phagocyte oxidase activation that rests heavily on conformational changes in the adaptor protein p47 phox . Do other agents, host factors akin to TNF␣ as well as microbial components such as endotoxin, share in their dependence on Pin1 activity for the capacity to prime NADPH oxidase activity? As several innate immune responses to microbial and endogenous danger signals overlap in other situations, it may be informative to determine the extent to which unrelated priming agents share mechanistic pathways. Likewise, examination of Pin1-dependent responses may elucidate fundamental elements of the excessive inflammatory activity seen in clinical settings such as adult respiratory distress syndrome, ventilator-associated pneumonia, or in pulmonary infections in patients with cystic fibrosis. Perhaps patients with excessive inflammatory responses that seem disproportionate to the type or magnitude of the offending agent, a clinical situation commonly seen by practicing allergists and immunologists, have abnormal Pin1 or aberrant Pin1 activity underlying their unchecked phagocyte activation.
As is always the case with novel work, the exciting findings reported by Boussetta et al not only provide important mechanistic insights into the immediate objective of their research (that is, the basis of TNF␣ priming of the phagocyte NADPH oxidase), but also inspire many provocative questions that extend to more general aspects of phagocyte biology and inflammation.
Conflict-of-interest disclosure: The author declares no competing financial interests. ■ The "age" of understanding VKA dose   ---------------------------------------------------------------------------------------------------------------- Neil A. Goldenberg and Mark A. Crowther UNIVERSITY OF COLORADO; MCMASTER UNIVERSITY Dose response to vitamin K antagonists (VKA) exhibits large within-and betweenindividual variation in both adults and children, presenting challenges to clinicians attempting to maximize the safety and efficacy of these agents. In part to address limitations with VKAs, alternative oral anticoagulant agents (eg, direct Xa and thrombin inhibitors) are being developed and evaluated in clinical trials. However, for the foreseeable future, VKAs will continue to be used given their familiarity, cost, and ease of access. Thus, anticoagulant research must continue to focus on optimizing use of these agents. 
